{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:00:11Z","timestamp":1767920411316,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,9,29]],"date-time":"2013-09-29T00:00:00Z","timestamp":1380412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s10552-013-0296-8","type":"journal-article","created":{"date-parts":[[2013,9,28]],"date-time":"2013-09-28T06:35:06Z","timestamp":1380350106000},"page":"2197-2206","source":"Crossref","is-referenced-by-count":18,"title":["Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer"],"prefix":"10.1007","volume":"24","author":[{"given":"M. T.","family":"Faber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Glud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"H\u00f8gdall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"H\u00f8gdall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Blaak\u00e6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. K.","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,29]]},"reference":[{"issue":"9609","key":"296_CR1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","volume":"371","author":"V Beral","year":"2008","unstructured":"Beral V, Doll R, Hermon C, Peto R, Reeves G (2008) Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 371(9609):303\u2013314","journal-title":"Lancet"},{"issue":"6","key":"296_CR2","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1158\/1055-9965.EPI-07-0089","volume":"16","author":"M S\u00f8gaard","year":"2007","unstructured":"S\u00f8gaard M, Jensen A, H\u00f8gdall E, Christensen L, H\u00f8gdall C, Blaak\u00e6r J et al (2007) Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study. Cancer Epidemiol Biomarks Prev 16(6):1160\u20131166","journal-title":"Cancer Epidemiol Biomarks Prev"},{"issue":"7716","key":"296_CR3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","volume":"2","author":"MF Fathalla","year":"1971","unstructured":"Fathalla MF (1971) Incessant ovulation\u2014a factor in ovarian neoplasia? Lancet 2(7716):163","journal-title":"Lancet"},{"issue":"1","key":"296_CR4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1525-1438.2006.00425.x","volume":"16","author":"I Konishi","year":"2006","unstructured":"Konishi I (2006) Gonadotropins and ovarian carcinogenesis: a new era of basic research and its clinical implications. Int J Gynecol Cancer 16(1):16\u201322","journal-title":"Int J Gynecol Cancer"},{"issue":"23","key":"296_CR5","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","volume":"90","author":"HA Risch","year":"1998","unstructured":"Risch HA (1998) Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90(23):1774\u20131786","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"296_CR6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/gyno.2001.6219","volume":"82","author":"K Ivarsson","year":"2001","unstructured":"Ivarsson K, Sundfeldt K, Brannstrom M, Janson PO (2001) Production of steroids by human ovarian surface epithelial cells in culture: possible role of progesterone as growth inhibitor. Gynecol Oncol 82(1):116\u2013121","journal-title":"Gynecol Oncol"},{"issue":"5","key":"296_CR7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1071-5576(98)00017-3","volume":"5","author":"GC Rodriguez","year":"1998","unstructured":"Rodriguez GC, Walmer DK, Cline M, Krigman H, Lessey BA, Whitaker RS et al (1998) Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis? J Soc Gynecol Investig 5(5):271\u2013276","journal-title":"J Soc Gynecol Investig"},{"issue":"7","key":"296_CR8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1600-0412.2012.01416.x","volume":"91","author":"NM Wilson","year":"2012","unstructured":"Wilson NM, Laursen M, Lidegaard O (2012) Oral contraception in Denmark 1998\u20132010. Acta Obstet Gynecol Scand 91(7):810\u2013815","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"296_CR9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/aje\/152.3.233","volume":"152","author":"RB Ness","year":"2000","unstructured":"Ness RB, Grisso JA, Klapper J, Schlesselman JJ, Silberzweig S, Vergona R et al (2000) Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. SHARE study group. Steroid hormones and reproductions. Am J Epidemiol 152(3):233\u2013241","journal-title":"Am J Epidemiol"},{"issue":"11","key":"296_CR10","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/0959-8049(92)90026-X","volume":"28A","author":"KA Rosenblatt","year":"1992","unstructured":"Rosenblatt KA, Thomas DB, Noonan EA (1992) High-dose and low-dose combined oral contraceptives: protection against epithelial ovarian cancer and the length of the protective effect. The WHO collaborative study of neoplasia and steroid contraceptives. Eur J Cancer 28A(11):1872\u20131876","journal-title":"Eur J Cancer"},{"issue":"7","key":"296_CR11","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/oxfordjournals.aje.a117055","volume":"139","author":"L Rosenberg","year":"1994","unstructured":"Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Lewis JL Jr, Strom BL et al (1994) A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. Am J Epidemiol 139(7):654\u2013661","journal-title":"Am J Epidemiol"},{"issue":"6","key":"296_CR12","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/1097-0215(20011120)95:6<370::AID-IJC1065>3.0.CO;2-T","volume":"95","author":"J Royar","year":"2001","unstructured":"Royar J, Becher H, Chang-Claude J (2001) Low-dose oral contraceptives: protective effect on ovarian cancer risk. Int J Cancer 95(6):370\u2013374","journal-title":"Int J Cancer"},{"issue":"9","key":"296_CR13","first-page":"720","volume":"45","author":"M Sanderson","year":"2000","unstructured":"Sanderson M, Williams MA, Weiss NS, Hendrix NW, Chauhan SP (2000) Oral contraceptives and epithelial ovarian cancer. Does dose matter? J Reprod Med 45(9):720\u2013726","journal-title":"J Reprod Med"},{"issue":"1","key":"296_CR14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.fertnstert.2004.03.013","volume":"82","author":"MC Pike","year":"2004","unstructured":"Pike MC, Pearce CL, Peters R, Cozen W, Wan P, Wu AH (2004) Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study. Fertil Steril 82(1):186\u2013195","journal-title":"Fertil Steril"},{"issue":"1","key":"296_CR15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/jnci\/94.1.32","volume":"94","author":"JM Schildkraut","year":"2002","unstructured":"Schildkraut JM, Calingaert B, Marchbanks PA, Moorman PG, Rodriguez GC (2002) Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk. J Natl Cancer Inst 94(1):32\u201338","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"296_CR16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/01.AOG.0000255664.48970.e6","volume":"109","author":"G Lurie","year":"2007","unstructured":"Lurie G, Thompson P, McDuffie KE, Carney ME, Terada KY, Goodman MT (2007) Association of estrogen and progestin potency of oral contraceptives with ovarian carcinoma risk. Obstet Gynecol 109(3):597\u2013607","journal-title":"Obstet Gynecol"},{"issue":"20","key":"296_CR17","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1001\/archinte.164.20.2253","volume":"164","author":"E Glud","year":"2004","unstructured":"Glud E, Kjaer SK, Thomsen BL, Hogdall C, Christensen L, Hogdall E et al (2004) Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Arch Intern Med 164(20):2253\u20132259","journal-title":"Arch Intern Med"},{"issue":"4","key":"296_CR18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00560348","volume":"7","author":"HM Bolt","year":"1974","unstructured":"Bolt HM, Bolt WH (1974) Pharmacokinetics of mestranol in man in relation to its oestrogenic activity. Eur J Clin Pharmacol 7(4):295\u2013305","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"296_CR19","first-page":"106","volume":"47","author":"RP Dickey","year":"1976","unstructured":"Dickey RP, Stone SC (1976) Progestational potency of oral contraceptives. Obstet Gynecol 47(1):106\u2013112","journal-title":"Obstet Gynecol"},{"issue":"5","key":"296_CR20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0010-7824(77)90077-4","volume":"16","author":"DW Hahn","year":"1977","unstructured":"Hahn DW, Allen GO, McGuire JL (1977) The pharmacological profile of norgestimate. A new orally active progestin. Contraception 16(5):541\u2013553","journal-title":"Contraception"},{"issue":"7","key":"296_CR21","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/sj.bjc.6601715","volume":"90","author":"M Kumle","year":"2004","unstructured":"Kumle M, Weiderpass E, Braaten T, Adami HO, Lund E (2004) Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian-Swedish Women\u2019s Lifestyle and Health Cohort Study. Br J Cancer 90(7):1386\u20131391","journal-title":"Br J Cancer"},{"issue":"10","key":"296_CR22","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/aje\/kwq264","volume":"172","author":"MG Braem","year":"2010","unstructured":"Braem MG, Onland-Moret NC, van den Brandt PA, Goldbohm RA, Peeters PH, Kruitwagen RF et al (2010) Reproductive and hormonal factors in association with ovarian cancer in the Netherlands cohort study. Am J Epidemiol 172(10):1181\u20131189","journal-title":"Am J Epidemiol"},{"issue":"6","key":"296_CR23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/humupd\/dmq022","volume":"16","author":"D Cibula","year":"2010","unstructured":"Cibula D, Gompel A, Mueck AO, La Vecchia C, Hannaford PC, Skouby SO et al (2010) Hormonal contraception and risk of cancer. Hum Reprod Update 16(6):631\u2013650","journal-title":"Hum Reprod Update"},{"issue":"5 Pt 1","key":"296_CR24","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0002-9378(99)70120-1","volume":"181","author":"R Rivera","year":"1999","unstructured":"Rivera R, Yacobson I, Grimes D (1999) The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol 181(5 Pt 1):1263\u20131269","journal-title":"Am J Obstet Gynecol"},{"key":"296_CR25","unstructured":"Rang HP, Dale MM, Ritter JM (1999) The reproductive system. In: pharmacology, 4th edn. Churchill Livingstone, Edinburgh, pp. 436\u201353"},{"issue":"4","key":"296_CR26","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/GRF.0b013e318159c06a","volume":"50","author":"J Kiley","year":"2007","unstructured":"Kiley J, Hammond C (2007) Combined oral contraceptives: a comprehensive review. Clin Obstet Gynecol 50(4):868\u2013877","journal-title":"Clin Obstet Gynecol"},{"issue":"9","key":"296_CR27","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/aje\/153.9.860","volume":"153","author":"DM Purdie","year":"2001","unstructured":"Purdie DM, Siskind V, Bain CJ, Webb PM, Green AC (2001) Reproduction-related risk factors for mucinous and nonmucinous epithelial ovarian cancer. Am J Epidemiol 153(9):860\u2013864","journal-title":"Am J Epidemiol"},{"issue":"4","key":"296_CR28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/aje\/kwf048","volume":"156","author":"T Riman","year":"2002","unstructured":"Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM et al (2002) Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. Am J Epidemiol 156(4):363\u2013373","journal-title":"Am J Epidemiol"},{"issue":"4","key":"296_CR29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/oxfordjournals.aje.a008937","volume":"144","author":"HA Risch","year":"1996","unstructured":"Risch HA, Marrett LD, Jain M, Howe GR (1996) Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Am J Epidemiol 144(4):363\u2013372","journal-title":"Am J Epidemiol"},{"issue":"4","key":"296_CR30","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/ijc.26469","volume":"131","author":"HP Yang","year":"2012","unstructured":"Yang HP, Trabert B, Murphy MA, Sherman ME, Sampson JN, Brinton LA et al (2012) Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study. Int J Cancer 131(4):938\u2013948","journal-title":"Int J Cancer"},{"issue":"2","key":"296_CR31","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2004.10.037","volume":"96","author":"AW Kurian","year":"2005","unstructured":"Kurian AW, Balise RR, McGuire V, Whittemore AS (2005) Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol 96(2):520\u2013530","journal-title":"Gynecol Oncol"},{"issue":"8","key":"296_CR32","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1047-2797(01)00213-7","volume":"11","author":"F Modugno","year":"2001","unstructured":"Modugno F, Ness RB, Wheeler JE (2001) Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness. Ann Epidemiol 11(8):568\u2013574","journal-title":"Ann Epidemiol"},{"issue":"7","key":"296_CR33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/aje\/kwg177","volume":"158","author":"KH Tung","year":"2003","unstructured":"Tung KH, Goodman MT, Wu AH, McDuffie K, Wilkens LR, Kolonel LN et al (2003) Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. Am J Epidemiol 158(7):629\u2013638","journal-title":"Am J Epidemiol"},{"key":"296_CR34","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","volume":"343","author":"\u00d8 Lidegaard","year":"2011","unstructured":"Lidegaard \u00d8, Nielsen LH, Skovlund CW, Skjeldestad FE, L\u00f8kkegaard E (2011) Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139. BMJ 343:d6423. doi: 10.1136\/bmj.d6423","journal-title":"BMJ"},{"issue":"7621","key":"296_CR35","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","volume":"335","author":"PC Hannaford","year":"2007","unstructured":"Hannaford PC, Selvaraj S, Elliott AM, Angus V, Iversen L, Lee AJ (2007) Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner\u2019s oral contraception study. BMJ 335(7621):651\u2013659","journal-title":"BMJ"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-013-0296-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-013-0296-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-013-0296-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T19:01:53Z","timestamp":1564167713000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-013-0296-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,29]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["296"],"URL":"https:\/\/doi.org\/10.1007\/s10552-013-0296-8","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,29]]}}}